Technical Analysis for MRNA - Moderna, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Down | Up |
| Historical MRNA trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Bearish Engulfing | Bearish | 0.00% | |
| 1,2,3 Retracement Bearish | Bearish Swing Setup | 0.00% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| 1,2,3 Retracement Bearish | Bearish Swing Setup | -2.31% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -2.31% | |
| Wide Bands | Range Expansion | -2.31% | |
| Up 3 Days in a Row | Strength | -2.31% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Outside Day | 3 days ago |
| Down 3% | 3 days ago |
| Non-ADX 1,2,3,4 Bearish Retracement Entry | 3 days ago |
| 1,2,3, Bearish Retracement Entry | 3 days ago |
| Fell Below Previous Day's Low | 3 days ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/04/2021
Moderna, Inc. develops medicines based on messenger RNA (mRNA). Its pipeline includes development candidates for mRNA-based vaccines and therapies for use in various therapeutic areas comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: S&P 500 Cancer Life Sciences Biology Nasdaq 100 Vaccine Coronavirus Cancer Vaccine RNA Cancer Vaccines Messenger RNA
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: S&P 500 Cancer Life Sciences Biology Nasdaq 100 Vaccine Coronavirus Cancer Vaccine RNA Cancer Vaccines Messenger RNA
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 497.17 |
| 52 Week Low | 65.49 |
| Average Volume | 16,838,954 |
| 200-Day Moving Average | 236.58 |
| 50-Day Moving Average | 391.20 |
| 20-Day Moving Average | 362.46 |
| 10-Day Moving Average | 316.85 |
| Average True Range | 23.11 |
| ADX | 31.9 |
| +DI | 17.75 |
| -DI | 30.05 |
| Chandelier Exit (Long, 3 ATRs) | 389.18 |
| Chandelier Exit (Short, 3 ATRs) | 362.90 |
| Upper Bollinger Bands | 466.26 |
| Lower Bollinger Band | 258.66 |
| Percent B (%b) | 0.32 |
| BandWidth | 57.28 |
| MACD Line | -23.98 |
| MACD Signal Line | -20.69 |
| MACD Histogram | -3.2871 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 358.78 | ||||
| Resistance 3 (R3) | 360.72 | 351.14 | 353.02 | ||
| Resistance 2 (R2) | 351.14 | 342.33 | 350.17 | 351.10 | |
| Resistance 1 (R1) | 337.67 | 336.89 | 332.88 | 335.73 | 349.18 |
| Pivot Point | 328.09 | 328.09 | 325.69 | 327.12 | 328.09 |
| Support 1 (S1) | 314.62 | 319.28 | 309.83 | 312.69 | 299.24 |
| Support 2 (S2) | 305.04 | 313.84 | 304.07 | 297.32 | |
| Support 3 (S3) | 291.57 | 305.04 | 295.40 | ||
| Support 4 (S4) | 289.64 |
